URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Road2HardCoreIron
  HTML https://road2hardcoreiron.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: HGH/ IGF1/ SLIN & Peptides
       *****************************************************
       #Post#: 1934--------------------------------------------------
       ANSWER SOME QUESTIONS ON IGF1
   DIR By: Road2HardCoreIron
       Date: December 10, 2022, 6:35 pm
       ---------------------------------------------------------
       Insulin-like Growth Factor 1, also known as IGF-1, is used as a
       biomarker for blood levels of human growth hormone. The blood
       level of IGF-1 appears to fluctuate over 24 hours and is found
       to be related to growth hormone secretion, hunger, sleep and
       exercise.
       It is a hormone produced by the liver and other tissues which
       affects growth-promoting activities and glucose metabolism.
       Because IGF-1 is related to the production and secretion of
       growth hormone (HGH), physicians may use this measurement to
       assess growth hormone status.
       
       IGF-1, What is it?
       IGF-1 is a hormone produced in our body that is structurally
       very similar to insulin. It has an important role in growth
       during childhood and in adulthood, continues to have anabolic
       effects. IGF-1 is the main mediator of the effects of growth
       hormone, which, most of us know, can benefit male physique
       drastically and also has anti-aging effects.
       
       What is the Relationship Between IGF-1 and GH?
       As stated previously, IGF-1 is the primary mediator of GH
       secretion. So what exactly does that mean? It all starts in an
       area of the brain called the hypothalamus. Whenever GH needs to
       be secreted (GH levels are typically highest during periods of
       fasting and sleep) the hypothalamus releases growth
       hormone-releasing hormone (GHRH). This GHRH then binds to
       receptors in another area of the brain called the anterior
       pituitary. The anterior pituitary then releases GH into the
       bloodstream. GH has several effects on the body including a
       glucose sparing effect- meaning that instead of the body
       utilizing glucose as a primary energy source, the body taps into
       adipose tissue, using stored fat as energy. In this regard, GH
       can significantly help to burn. However, this is not the only
       favorable action of GH. GH also has several anabolic growth
       effects. It increases the uptake of amino acids from the blood
       and increases protein synthesis in skeletal muscle tissue. This
       anabolism however, can be come problematic due to the fact that
       GH also targets bone cells and just about every other cell in
       the body.
       Excessive GH use can lead to a condition called acromegaly,
       which is characterized by uncontrolled bone growth. The most
       noticeable feature of someone with acromegaly or HGH abuse is
       the development of a jagged/uncharacteristically large jawline.
       Some oncologist fear that increased IGF-1 may accelerate certain
       cancers, but studies on this subject are contradictory.
       Where does IGF-1 come into play?
       GH acts directly on the liver to produce IGF-1
       This IGF-1 is then released into the blood stream to further
       stimulate the growth effects of GH. These two hormones work
       synergistically to promote cellular growth effects to the bone
       cells, muscle cells, nervous system cells, immune cells, and
       just about every cell in our body. GH also has a “diabetogenic
       effect”, meaning that when GH binds to receptors on the liver,
       the liver is instructed to break down glycogen into glucose,
       which fuels growth effects.
       Other benefits and effects of IGF-1
       Interestingly enough, elevated IGF-1 levels (from elevated GH
       levels) may potentially have a beneficial effect on erectile
       dysfunction [1]. In 2011 a paper titled “IGF-1 levels are
       significantly correlated with patient-reported measures of
       sexual function” Growth hormone (GH) supplementation may help to
       preserve erectile function. Researchers assessed whether serum
       insulin-like growth factor 1 (IGF-1) levels, a surrogate for GH
       levels, correlated with sexual function scores in 65 men who
       completed the Sexual Health Inventory for Men (SHIM) and
       Expanded Prostate Cancer Index Composite (EPIC) questionnaires,
       and had serum IGF-1 and testosterone levels determined.
       Median±s.d. IGF-1 level, SHIM and EPIC scores were 235.0±86.4,
       19.5±8.7 and 56.4±28.3 mg ml−1, respectively. IGF-1 levels
       and total SHIM score correlate significantly (r=0.31, P=0.02),
       as do IGF-1 levels and all individual SHIM question scores, and
       IGF-1 levels and the sexual domain of the EPIC questionnaire
       (r=0.30, P=0.02)
       The second figure below represents the total Sexual Health
       Inventory for Men (SHIM) score vs serum insulin-like growth
       factor (IGF-1) level. All subjects' IGF-1 levels plotted against
       their self-reported scores of sexual function based on total
       SHIM score. There is a statistically significant correlation
       between the two measured values, (Spearman's correlation
       coefficient, r=0.31; P=0.02).
       Another study published titled “Men with high levels of anabolic
       hormones less likely to develop worsening frailty” Proved that
       having higher baseline levels of vitamin D, insulin-like growth
       factor-1 (IGF-1) and its binding protein 3 (IGFBP3) was
       associated with a lower risk of worse frailty status four years
       later [2]. "Vitamin D, besides maintaining bone health,
       regulates muscle function, and low vitamin D levels are linked
       to lower muscle mass and strength. IGF-1 affects muscle growth
       and repair, and its action and levels are modified by its
       carrier protein IGFBP3," Swiecicka said.
       Also linked to a lower likelihood of frailty status worsening
       were higher baseline levels of the hormone
       dehydroepiandrosterone sulfate (DHEA-S), but only in the oldest
       men. Several potential pathways could link DHEA-S with frailty.
       Swiecicka said, "DHEA-S may have direct anabolic effect on
       muscle, and, more recently, its neuroprotective and immune
       system-modulating effects have been described."
       Products that naturally raise IGF-1 levels
       How might we safely raise GH and IGF-1 levels? There are two
       types of drugs that can safely raise GH and IGF-1 levels without
       greatly exceeding normal physiological levels (the higher we
       exceed normal physiological levels the greater the risk for
       unwanted pathology such as acromegaly and enlarged organs).
       These two types of drugs are:
       1. Growth Hormone Secretagogues
       2. Growth Hormone Releasing Hormone Mimetics
       Growth Hormone Secretagogues (GHS)
       GHSs are typically sequences of connected peptides (called
       Growth Hormone Releasing Peptides) that bind to the GHS
       receptor[3]. These receptors are present in many areas of the
       body, but of importance, in the hypothalamus and anterior
       pituitary, the areas responsible for GH release. The natural
       ligand to the GHS receptor in the body is ghrelin, the hormone
       responsible for sensing hunger and speeding up gastric emptying.
       This is why when GHRP-6 is administered subcutaneously, the
       patient will often report voracious hunger. This effect may be
       beneficial to those who have trouble consuming enough food to
       gain weight and muscle mass. Not only does this drug induce
       hunger but it causes a large but very shortly sustained release
       in GH. Typically this GH “spike” only lasts about 4 hours
       (GHRP-6 has a very short half-life in the body). This short
       duration disallows a proportional IGF-1 response from the liver.
       This problem was solved with the invention of Ibutamoren.
       Ibutamoren is a non-peptidic compound (vs peptidic GHRPs) that
       binds to the GHS receptor.
       Ibutamoren, as a ligand, acts directly on arcuate neurons of
       hypothalamus to stimulate the release of GHRH. Activation of
       these neurons by ibutamoren can be inhibited by sst
       (somatostatin) or pretreatment with GH (IGF-1 Feedback
       inhibition) [3].
       An initial dose of ibutamoren causes a large spike in growth
       hormone levels (following normal physiologic pulsatile
       secretion) along with a large spike in cortisol. Subsequent and
       continued daily administration causes (comparatively) much
       smaller spikes in GH. IGF-1 levels become and stay elevated
       without a cortisol spike. If a dose is missed within 24 hours
       (half life of ibutamoren is 24 hours), IGF-1 will drop due to
       decreased liver stimulation from GH output. GHRH secretion is
       slowed by the continuously higher IGF-1 concentration, creating
       a safe negative feedback loop [3]. GHRPs DO NOT have a negative
       feedback loop because the GH spike is not sustained long enough
       (due to a short 4 hour half life) to allow for a sustained
       increase in IGF-1 (unless taken every few hours over a couple of
       days) GHRPs also do not allow for normal physiologic pulsatile
       function (which ibutamoren mimics). This negative feedback loop
       makes ibutamoren relatively very safe when compared to exogenous
       GH administration.
       Growth Hormone Releasing Hormone Mimetics
       These peptides mimic the hormone GHRH. GHRH is released from the
       hypothalamus and it binds to receptors on the anterior
       pituitary. The anterior pituitary then releases growth hormone
       into the bloodstream. The most popular GHRH mimetic is
       Sermorelin. It binds to the GHRH receptors of the hypothalamus
       and causes a marked increase in GH levels and IGF-1 levels.
       Notice that GH Secretagogues bind to the GHS receptor and GHRH
       mimetics bind to the GHRH receptor. This means that there are
       two different pathways used to increase natural GH and IGF-1
       production. If a GHRH mimetic is used along with a GHS, the
       synergistic effect should markedly increase natural GH and IGF-1
       production.
       IGF-1 in Relation to Testosterone
       In a study titled “Testosterone administration increases
       insulin-like growth factor-I levels in normal men.” Researchers
       discovered just that [4]. Although testosterone (T)
       administration can increase insulin-like growth factor-I (IGF-I)
       when administered to hypogonadal men, no studies have examined
       whether this occurs in normal men. The present study was
       undertaken to determine if an increase in IGF-I may be part of
       the anabolic effect of androgens. Researchers enrolled 11 normal
       men in a randomized, double-blinded cross-over study. Subjects
       were assigned to receive either T enanthate (TE) (300 mg im,
       each week) or nandrolone (ND) decanoate (300 mg im, each week)
       for 6 weeks. After a washout period subjects were administered
       the alternate treatment. Pre- and posttreatment serum was
       analyzed for IGF-I by RIA after acid-ethanol extraction.
       Although GH levels were not significantly different after either
       TE or ND treatment, they tended to increase after TE treatment
       (1.23 +/- 0.28 ng/mL vs. 3.3 +/- 1.03 ng/mL) but remained
       unchanged after ND treatment (1.68 +/- 0.68 ng/mL vs. 1.89 +/-
       0.64 ng/mL). Serum total T levels increased 32 +/- 0.05 nmol/L
       in the TE-treated men, but fell by 7 +/- 0.02 nmol/L in the
       ND-treated men (P < 0.0001). These data indicate that when
       normal men are given TE, serum IGF-I levels increase after 6
       weeks of treatment.
       IGF-1 Blood Test: Everything You Need to Know
       
       IGF-1 stands for insulin-like growth factor. It's an essential
       hormone in the human body, and it's very similar to the insulin
       produced by your pancreas. An IGF-1 blood test is increasingly
       popular these days since this hormone plays a significant role
       in the numerous metabolic processes of the body.
       But when was the last time you did an IGF-1 blood test? And why
       should you do one? Keep reading this article to learn everything
       you need to know about IGF-1 and its importance for human
       health.
       What Is an IGF-1 Blood Test?
       IGF-1 works in tandem with the growth hormone produced by your
       pituitary gland. The IGF-1 hormone plays an important role,
       particularly in childhood. It helps with the process of growing
       bones, muscles, and tissues.
       An IGF-1 test uses a sample of your blood to measure how much of
       this hormone is circulating through your bloodstream. Having low
       levels of IGF-1 might show some effects, as you'll see later in
       this article.
       In adulthood, IGF-1 continues to influence your health
       significantly. For example, it plays an essential role in tissue
       repairs, maintains healthy bones, and, more importantly, helps
       develop lean muscle mass.
       What Does IGF-1 Do In the Body
       Let's take a closer look at the most critical functions of IGF-1
       to understand how important it is for your health. For example,
       IGF-1 is responsible for increasing muscle mass, provided that
       the person in question also works out regularly.
       IGF-1 also maintains lean muscle and prevents a process known as
       atrophy. It also stimulates the growth of bones, and it provides
       energy for the body to do tissue repair processes such as for
       healing wounds and so on.
       On top of that, IGF-1 also plays a crucial role in lipid
       metabolism. This means the process of burning fats stored
       throughout your body. In some cases, overweight and obese people
       might also struggle with IGF-1 deficiency as this hormone is
       vital for fat metabolism.
       IGF-1 also helps with glucose metabolism. Glucose is also known
       as blood sugar and it's the main source of fuel for your body.
       Glucose is pushed by insulin into cells to produce energy. IGF-1
       helps with this process, so the sugar in your blood is used
       effectively.
       Symptoms of Having Low IGF-1 Levels
       Having too much IGF-1 is rare, and it might happen during the
       early stages of life. In such cases, children grow very tall,
       and this condition is known as gigantism. Low IGF-1 issues are
       more prevalent, and they can affect both children and adults.
       For example, here are the main symptoms of having too little
       IGF-1 in your system.
       Anxiety and depression
       Excessive fatigue
       Low exercise performance
       Loss of muscle mass
       Thin skin that gets wounded easily
       Reduced bone density
       Some of these effects might be subtle, and you might not even
       know that they are caused by too little IGF-1 in your body.
       Also, many of these symptoms are shared by other health
       conditions, so it can be tricky to identify which ailment is the
       culprit.
       That's why it's essential to do an IGF-1 test if you feel
       lethargic most of the time. Excessive tiredness might be caused
       by various factors such as low testosterone, low blood iron
       levels, but also because you might have too little IGF-1.
       Causes of Low IGF-1
       There are a few reasons why people might experience low levels
       of IGF-1 in the body. Remember that the pituitary gland produces
       a growth hormone that works in tandem with IGF-1. IGF-1 itself
       is mainly produced in the liver but also in other parts of the
       body.
       One reason you might have low levels of IGF-1 is an underactive
       pituitary gland. This might be accompanied by low levels of
       thyroid hormones since the thyroid is also stimulated by the
       pituitary. In rare cases, pituitary tumors might prevent the
       proper release of growth hormone too.
       Since IGF-1 works together with growth hormone, an insensitivity
       to GH might also cause symptoms such as the ones mentioned
       above. This problem can be genetic or inherited. For example,
       those with kidney or liver disease might develop an
       insensitivity to GH, which would result in low IGF-1 levels.
       IGF-1 in Relation to Testosterone and ED
       A couple of studies done in the last decade look at the link
       between IGF-1 and testosterone. It has been discovered that
       administering higher doses of testosterone exogenously might
       increase IGF-1 levels also. This means the administration of
       testosterone using creams, injections, or other methods.
       Men on testosterone replacement therapy might benefit from this
       type of treatment by seeing their IGF-1 levels go up. The study
       data suggest that this increase is visible after at least six
       weeks of TRT.
       At the same time, having higher IGF-1 levels might also
       alleviate erectile dysfunction in some men. ED is a prevalent
       problem for those with low testosterone levels and/or seniors. A
       study found that increasing IGF-1 levels (as well as GH levels)
       could improve sexual function in men.
       Having more IGF-1 is likely more beneficial for adults than
       having less of it. That's why you might be interested in natural
       ways you can increase IGF-1. This is entirely possible, and one
       of the simplest ways to do it is to lose body fat.
       Excessive fat automatically lowers IGF-1 levels, so you might
       want to increase your weekly exercising time to lose weight.
       Fasting can also be used to increase IGF-1 levels. There are
       many types of fasting, and intermittent fasting is one of the
       most popular types.
       Order The IGF-1 Lab Test Today!
       As you can see, the increasing interest in IGF-1 is justified as
       this hormone is so important when it comes to your health. If
       you experience some of the symptoms mentioned above or you want
       to see how you stand, make sure that you order an IGF-1 blood
       test as soon as possible.
       To get excellent value for money and receive the results in just
       a few business days, go to DiscountedLabs.com and order the
       affordable IGF-1 lab test today!
       
       IGF-1 Reference Range(s)
       
       Pediatric
       <1 Years
       1-1.9 Years
       2-2.9 Years
       3-3.9 Years
       4-4.9 Years
       5-5.9 Years
       6-6.9 Years
       7-7.9 Years
       8-8.9 Years
       9-9.9 Years
       10-10.9 Years
       11-11.9 Years
       12-12.9 Years
       13-13.9 Years
       14-14.9 Years
       15-15.9 Years
       16-16.9 Years
       17-17.9 Years
       
       Adult
       18-19.9 Years
       20-24.9 Years
       25-29.9 Years
       30-39.9 Years
       40-49.9 Years
       50-59.9 Years
       60-69.9 Years
       70-79.9 Years
       >80 Years
       
       Z-Score (Male)
       Z-Score (Female)
       
       References:
       1. Pastuszak AW, Liu JS, Vij A, Mohamed O, Sathyamoorthy K,
       Lipshultz LI, Khera M. IGF-1 levels are significantly correlated
       with patient-reported measures of sexual function. Int J Impot
       Res. 2011 Sep-Oct;23(5):220-6
       2. Smith, Roy G. Human Growth Hormone Research and Clinical
       Practice.
       3. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone
       administration increases insulin-like growth factor-I levels in
       normal men. J Clin Endocrinol Metab. 1993 Sep;77(3):776-9.
       4. Agnieszka Swiecicka, Mark Lunt, Tomas Ahern, Terence W.
       O'Neil. Higher Anabolic Hormone Levels Predict Lower Risk of
       Worsening Frailty in Men: Prospective Results from the European
       Male Ageing Study. Presented at Endocrine Society Annual Meeting
       2017
       
       *****************************************************
       Page 1 of 1